Understanding interaction mechanisms is essential for safe prescribing and deprescribing
PMID: 29634344
By comparing -MSH with its analogs, we see how structural changes in peptides can modify receptor selectivity, potency, and therapeutic potential
Typically, it is administered via subcutaneous injection, in most cases once a week, with the option to adjust the dosage, if necessary, after the first month
We recommend a plan based on your health condition and goals
Key properties: Does not increase cortisol important for avoiding stress hormone elevation Does not increase prolactin no hormonal disruption Minimal ghrelin-like hunger suitable when appetite stimulation is unwanted Dose-dependent GH release predictable, linear response This selectivity makes Ipamorelin the go-to choice when a clean GH pulse is the primary goal without metabolic side effects